HERMES ARZNEIMITTEL
HERMES ARZNEIMITTEL is a german OTC pharmaceuticals and consumer health brand company.
Analyst Perspective
HERMES ARZNEIMITTEL GmbH is a German consumer-health and pharmaceutical company focused on over-the-counter medicines, dietary supplements and related health brands. It develops, manufactures, markets and distributes more than 30 OTC brands, primarily through pharmacies in Germany and through export partners in roughly 25 countries. The company operates as part of the HERMES Group under the Johannes Burges Family Foundation. The company generates revenue from product sales across its owned and managed OTC portfolio, supported by pharmacy-channel relationships, brand lifecycle management and selected portfolio acquisitions. Its direct customers are pharmacies, healthcare retailers and international distribution partners, while end consumers are reached through those channels. Hermes Experts extends this model with a professional information portal for pharmacists, supporting sell-through and advisory quality rather than acting as a standalone software business.
Analyst Signal Briefing
Updated: 3 Jul 2026No strategic news signals detected in the last 90 days.
Explorer Tier
Start exploring for free
Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.
- View public Company Profiles
- Save/watch companies
- Build your first Watchlist
- Access additional market signals
Key insights about HERMES ARZNEIMITTEL
Category Differentiation
This is a German OTC pharmaceuticals and consumer-health company, not a logistics firm, courier brand or adtech platform. It sells healthcare products through pharmacies and export partners rather than software or media services.
HERMES ARZNEIMITTEL: About
The company creates value by owning and managing a portfolio of OTC healthcare brands, developing and manufacturing formulations, and distributing them through pharmacy-led channels and export partners. Its model combines brand building, regulated product commercialisation, channel management and international distribution, with portfolio expansion through acquisitions of established OTC assets.
How HERMES ARZNEIMITTEL Works & Monetises
Business model analysis and core revenue streams
HERMES ARZNEIMITTEL monetises through wholesale and channel sales of OTC medicines, supplements and consumer health products under proprietary and acquired brands. Revenue is driven mainly by physical product sales, supported by export distribution agreements and brand portfolio management. The Hermes Experts portal functions as a channel-enablement asset rather than a separate SaaS revenue line.
Revenue Channels
Products & Services in Categories
Verified structural categorizations from the graph
HERMES ARZNEIMITTEL: Frequently Asked Questions
What is HERMES ARZNEIMITTEL?
HERMES ARZNEIMITTEL is a German pharmaceutical and consumer-health company that develops, manufactures, markets and distributes OTC medicines and health brands.
Who uses HERMES ARZNEIMITTEL?
Its direct customers are pharmacies, healthcare retailers and international distribution partners, while pharmacists also use its professional information portal.
How does HERMES ARZNEIMITTEL make money?
It makes money mainly from selling OTC medicines, supplements and consumer health products through pharmacy channels and export partnerships.
Company Facts
- Founded
- 1907
- Headquarters
- Germany
- Core Segment
- Other / Non-Digital Advertising Relevant
- Company Size
- 50–200
- Official Link
- hermes-arzneimittel.com